1596 / 1835
Future Directions
1. Expand and validate gene expression signatures in entire
low grade lymphoma cohort
2. Translate signatures back to laboratory for functional
studies
3. Expand collaboration to other centers/institutes
4. Adapt the proposed workflow to other lymphoma subtypes